MHRA Guidance on First-in-Human Studies in the UK
MHRA Guidance on First-in-Human Studies in the UK First-in-Human Clinical Trials in the United Kingdom: MHRA Guidance First-in-human (FIH) studies mark a pivotal step in the clinical development of investigational medicinal products. These early-phase trials are conducted after preclinical evidence suggests acceptable safety, typically involving healthy volunteers or carefully selected patient groups. In the United…
Read More “MHRA Guidance on First-in-Human Studies in the UK” »